A breakthrough in diabetic nephropathy: the role of endothelial dysfunction.
Nakagawa
Takahiko
T
Division of Nephrology, Hypertension and Transplantation, University of Florida, PO Box 100224, Gainesville, FL 32610-0224, USA. nakagt@medicine.ufl.edu
Segal
Mark
M
Croker
Byron
B
Johnson
Richard J
RJ
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D003928:Diabetic Nephropathies / Q000503:physiopathology* / Q000628:therapy*; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000473:pathology*; D006801:Humans; D007678:Kidney Glomerulus / Q000473:pathology; D051379:Mice; D018345:Mice, Knockout; D008954:Models, Biological; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D014652:Vascular Diseases / Q000503:physiopathology*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D014665:Vasodilator Agents / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D042461:Vascular Endothelial Growth Factor A; D014665:Vasodilator Agents; D052250:Nitric Oxide Synthase Type III